道琼斯今日:市场分析 Finance

道琼斯今日:市场分析

` tags. Here's the translated content: ```xml (SeaPRwire) - 道琼斯工业平均指数今天经历了波动,反映了更广泛的市场情绪。投资者正在密切关注经济指标和企业盈利报告。近期经济形势的发展导致股市波动,道琼斯指数在涨跌之间震荡。分析师认为,市场正在对多种因素做出反应,包括地缘政治紧张局势和财政政策的变化。 随着交易日的展开,主要行业出现了显著的变动。科技板块表现出韧性,其中像Apple (NASDAQ:AAPL)这样的公司领涨。Apple强劲的季度收益报告提振了投资者信心,反映了消费者对其产品的强劲需求。同样,金融板块的表现喜忧参半,一些银行报告的利润高于预期,而另一些银行则因利率波动而面临挑战。 能源股也引起了人们的关注,因为石油价格持续影响着市场动态。欧佩克成员国之间关于产量水平的持续讨论造成了不确定性,影响了与石油相关的股票。此外,汽车行业正在经历转型,各公司都在大力投资电动汽车,其中Tesla (NASDAQ:TSLA) 处于这场转型的前沿。 此外,医疗保健股正受到密切关注,因为该行业正在适应监管变化和医疗技术的创新。该行业的公司正专注于推进研发,以保持在市场上的竞争力。相比之下,房地产市场正面临着由于利率上升而带来的压力,这影响了购房者的负担能力,并减缓了房地产市场的增长。 总的来说,市场专家建议采取谨慎的态度,因为经济形势仍然不明朗。建议进行多元化和战略性投资,以降低风险并利用潜在的增长机会。建议投资者随时了解可能影响市场趋势的全球事件和经济政策。 脚注: 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 道琼斯指数反映了投资者情绪和经济状况。. ```
More
Endless 宣布与萨里大学合作,加速 Web3 和 AI 创新 Finance

Endless 宣布与萨里大学合作,加速 Web3 和 AI 创新

(SeaPRwire) - LONDON, March 24, 2025 — Endless 很高兴地宣布与 University of Surrey 建立新的合作伙伴关系,这标志着 Endless 生态系统向前迈出的重要一步。通过将先进的 Web3 解决方案与最先进的 AI 技术相结合,此次合作将扩大 Endless 的decentralized生态系统的范围,同时使 Web3 DApp 开发更快、更用户友好。 Endless 是一个 decentralized 智能组件协议,旨在帮助开发者轻松创建安全高效的 Web3 应用程序,同时保障隐私、资产安全和数据控制。凭借内置的 AI 功能,Endless 使开发者能够无缝地将人工智能融入其去中心化应用程序 (DApps) 并创建链上 AI 代理。 Endless 的使命是为 Web2 应用程序过渡到 Web3 铺平道路,为开发者提供构建 Web3 应用程序的一站式商店,并为用户提供流畅的 Web2 级别体验。 此次合作是 Endless 推动 Web3 技术的使命支柱之一。通过与 University of Surrey 共同开发新的开源框架,Endless 不仅简化了 DApps 的开发流程,还通过 AI 功能增强了生态系统。开发者可以构建具有强大智能和可扩展性的应用程序。 University of Surrey 在机器学习算法和 AI 技术框架方面均处于世界领先地位。与以其 AI 实力而闻名的 University of Surrey 的合作,使 Endless 处于区块链技术中 AI 的前沿。 Endless 希望激励新一波开发者探索 Web3 与 AI 的融合,从而促进向更加 decentralized、AI 赋能的数字未来转变,从而确保隐私、安全和用户赋权。 Endless 和 University of Surrey 共同的愿景是利用尖端技术创建一个由 AI 增强的decentralized、以用户为中心的数字景观。通过结合他们的专业知识,Endless Protocol 和 University of Surrey 将共同努力推动 Web3 和 AI 应用程序的发展。 Endless Web3 Genesis Cloud 的 CTO Dr Amit Kumar Jaiswal 说:“我们正在引领一场革命,通过 AI 驱动的自动化和无缝的区块链集成来消除 Web3 的复杂性。这不仅仅是技术,而是关于赋权。我们与 University of Surrey 的战略合作伙伴关系放大了这一使命,为真正去中心化的智能数字世界开辟了道路。我们不仅仅是在构建工具,我们还在创造体验。我们的目标是消除摩擦,使 Web3 像网络本身一样直观和易于访问,确保创新使每个人受益,而不仅仅是少数人。此次合作标志着一个关键的飞跃,它将改变开发者和用户与 DApps 交互的方式,从而开创一个 AI 和区块链融合以创建以用户为中心的decentralized未来的时代。正如 Alan Kay 所说,‘预测未来的最佳方式是创造它。’在 Endless,我们正在积极创造一个以用户为中心、智能化 decentralized 的数字世界。” SABMA(Surrey Academy for Blockchain and Metaverse Applications)副主任 Senmao Xia 博士补充说:“AI 和 Web3 正在重塑我们与技术的关系,为创新、安全和数字所有权释放新的机遇。与 Endless Web3 Genesis Cloud 合作让我们能够深入研究这些可能性,将尖端研究与实际解决方案联系起来,从而赋能用户、企业和下一代创新者。” 关于 Endless Web3 Genesis Cloud Endless Web3 Genesis Cloud 是一个分布式智能组件协议,致力于减少 Web2 应用程序过渡到 Web3 的障碍,为开发者提供一站式 Web3 应用程序开发平台,并为用户提供 Web2 级别的体验。Endless 由基于 Move 语言的公链驱动,集成了各种 AI 功能和插件,致力于成为 AI 和 Crypto 之间最好的连接器。它允许开发者以组件化的方式更简单、更快速地构建 Crypto AI 应用程序,从而促进 AI Agentic Super Intelligent System 的到来。 更多信息,请访问: | 关于 University of Surrey University of Surrey 是一所研究密集型机构,以其世界领先、具有影响力的研究和卓越的教学而闻名。该大学致力于通过创新和合作来改变生活并推动积极的变革。该大学在英国的人工智能领域一直排名第一。 来源:Endless本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。 ```
More
WuXi Biologics连续第八年荣获CDMO领导奖 Finance

WuXi Biologics连续第八年荣获CDMO领导奖

` tags. `` (SeaPRwire) - SHANGHAI, March 23, 2025 — WuXi Biologics (“WuXi Bio”) (2269.HK), 一家领先的全球合同研究、开发和生产组织 (CRDMO),宣布其已荣获 2025 年度 CDMO Leadership Awards 的“生物制剂 – 全球”类别奖项。同时,凭借在“最佳科学专业知识”、“最佳跨阶段无缝交付”和“技术与工艺执行的最佳创新方法”方面的卓越表现而备受认可,成为本次颁奖典礼上最受赞誉的公司。 这是WuXi Biologics连续第八年荣获 CDMO Leadership Award,彰显了其致力于推进综合技术平台,加速生物制剂的发现、开发和生产的承诺。公司已将单克隆抗体项目从DNA到研究性新药 (IND) 申请的开发时间缩短至 9 个月,最近一个自身免疫疾病项目仅用了 6 个月就完成了。通过利用一次性使用技术 (SUT),该公司在全球工厂实现了从 4,000 升到 16,000 升的生产规模扩大,成功率高达 99% (2022-2024)。在同等规模下,SUT 生产成本与不锈钢系统相当。这些里程碑的取得得益于其世界一流的质量体系,该体系确保了 100% 的预批准检查 (PAI) 成功率,并通过了全球监管机构的 40 多次检查,其中包括 FDA 和 EMA 进行的 22 次检查。 WuXi Biologics 首席执行官 Chris Chen 博士评论说:“我们很荣幸连续第八年荣获 CDMO Leadership Award。这一成就反映了我们全球合作伙伴的信任以及我们团队的不懈奉献。我们致力于帮助我们的合作伙伴快速有效地向市场交付拯救生命的疗法,从而造福全球患者。” CDMO Leadership Awards 由 Outsourced Pharma 和 Life Science Leader 颁发。在 2025 年的奖项评选中,基于权威的第三方研究对 210 家 CDMO 进行了评估。这些奖项旨在表彰四个类别(生物制剂、细胞和基因治疗、小分子 API、小分子剂型)以及三个服务区域(全球、北美和国际)中的顶级 CDMO。 关于WuXi Biologics WuXi Biologics(股票代码:2269.HK)是一家领先的全球合同研究、开发和生产组织 (CRDMO),提供端到端解决方案,助力合作伙伴发现、开发和生产生物制剂——从概念到商业化——从而造福全球患者。 WuXi Biologics 在中国、美国、爱尔兰、德国和新加坡拥有超过 12,000 名技术精湛的员工,利用其技术和专业知识为客户提供高效且具有成本效益的生物制剂发现、开发和生产解决方案。截至2024年12月31日,WuXi Biologics 正在支持 817 个综合客户项目,其中包括 21 个商业生产项目(不包括 COVID CMO 项目)。 WuXi Biologics 认为可持续发展是长期业务增长的基石。公司不断推动绿色技术创新,为全球合作伙伴提供先进的端到端绿色 CRDMO 解决方案,同时在环境、社会和治理 (ESG) 方面始终追求卓越。公司致力于创造共享价值,与所有利益相关者合作,以促进积极的社会和环境影响,并推广能够增强整个价值链的负责任的实践。 有关WuXi Biologics的更多信息,请访问: 联系方式 媒体 商务 SOURCE WuXi Biologics本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More
Fujitsu 与 QuTech 实现高精度量子门 Finance

Fujitsu 与 QuTech 实现高精度量子门

Fujitsu 和 QuTech 在金刚石自旋量子比特的完整通用量子门集中,实现了世界首个低于 0.1% 的误差概率,超过了量子纠错的阈值,这是实现容错量子计算和量子计算机实际应用的重要一步。 使用碳-13 同位素浓度降低的高纯度金刚石和先进的性能测量技术,在单量子比特和双量子比特门操作中实现了超过 99.9% 的保真度,最大限度地减少了环境噪声。 未来的合作将侧重于通过增加量子比特的数量以及开发先进的光互连和控制电路来扩大系统规模。 (SeaPRwire) - KAWASAKI, Japan, March 24, 2025 — Fujitsu Limited 今天宣布,首次演示了金刚石自旋量子比特的完整通用量子门集,其误差概率低于 0.1%,实现了所有量子硬件技术中报告的最高保真度之一。与 Delft University of Technology 的领先量子技术研究机构 QuTech 的合作,标志着金刚石自旋方法朝着进行量子纠错和实现实用量子计算迈出了重要一步。该发现于 2025 年 3 月 21 日发表在 Physical Review Applied 上。 新开发的技术利用高纯度金刚石来创建一个稳定的双量子比特系统,该系统包含氮空位中心内的电子自旋和氮核自旋,氮空位中心是一种可用于量子计算的原子缺陷。该团队使用先进技术消除了环境噪声对量子比特的影响,并测量了量子门的性能,在通用门集中,单量子比特和双量子比特门的保真度均超过 99.9%。这超过了量子纠错所需的阈值。 展望未来,Fujitsu 和 QuTech 将继续合作,增加使用的量子比特数量,并开发光学量子芯片和控制电路,以推进金刚石自旋量子计算机的早期实际应用研究。 未来计划 展望未来,Fujitsu 和 QuTech 将专注于将新开发的技术应用于具有更多核自旋的系统,并开发用于远距离电子自旋量子比特之间的高精度光互连技术,以增加可管理的量子比特数量。此外,该团队将加速研究和开发,以实现可扩展的量子计算系统,包括使用低温 CMOS 低温半导体集成电路的控制电路的集成技术。 SOURCE Fujitsu Limited本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More
Cambridge 欢迎 Sean Van Moorleghem 担任执行副总裁兼首席技术官 Finance

Cambridge 欢迎 Sean Van Moorleghem 担任执行副总裁兼首席技术官

(SeaPRwire) - 在Charles Schwab推动数字化转型和人工智能集成方面拥有良好记录的Van Moorleghem将担任Cambridge的关键领导职务 FAIRFIELD, Iowa, March 24, 2025 — Cambridge Investment Research, Inc. (“Cambridge“),一家为全国3,800名顾问提供服务的领先独立金融解决方案公司,很高兴地欢迎Sean Van Moorleghem担任执行副总裁兼首席技术官。 在这个职位上,Van Moorleghem将领导Cambridge的技术创新,负责开发和执行创新产品、服务和系统,从而推动公司及其顾问的增长。他同时也会加入Cambridge的执行委员会,并与执行领导一起支持公司范围内的战略目标。 创新与体验总裁Colleen Bell表示:“Sean是一位经验丰富的技术专家,在业内一些最大的公司领导成功的数字化转型方面拥有令人印象深刻的记录。 当我们继续致力于构建行业领先的技术平台时,Sean在技术、数字化转型和人工智能个性化方面的领导经验将是无价的。我很高兴他能加入我们的Cambridge大家庭。” Van Moorleghem 从Charles Schwab加入Cambridge,在2020年被Schwab收购之前,他曾在TD Ameritrade担任多个以技术为中心的领导职务。在Schwab/TD Ameritrade近15年的任期内,他领导了多个软件工程部门,并在推进平台现代化、实施人工智能驱动的自动化以及支持公司从基于项目的投资策略向以产品为中心的投资策略转型方面发挥了重要作用。他丰富的技术经验还包括在West Corporation、First Data Corporation和Deloitte担任领导职务。 Van Moorleghem获得了University of Nebraska的管理信息系统学士学位,并在University of Pennsylvania的Wharton School完成了证券行业学院(SII)高管领导力项目。 关于CambridgeCambridge是一家金融解决方案公司,专注于服务独立的金融专业人士及其客户,同时保持其内部控制。Cambridge为独立的金融专业人士提供广泛的选择,包括关于建议、增长、技术和独立性的解决方案。Cambridge的全国业务范围包括:Cambridge Investment Research Advisors, Inc. – 一家大型企业RIA;以及Cambridge Investment Research, Inc. – 一家独立的经纪自营商,是FINRA/SIPC的成员,也是美国国内最大的内部控制独立经纪自营商之一。 欲了解更多信息,请访问。 联系方式: Jeff Wulf, Senior Vice President, Cambridge: 或 800-777-6080 通过Cambridge Investment Research, Inc.(经纪自营商,FINRA/SIPC成员)提供的证券,以及通过Cambridge Investment Research Advisors, Inc.(注册投资顾问)提供的投资咨询服务。两者均为Cambridge Investment Group, Inc.的全资子公司。 来源:Cambridge本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More
Sonae 报告2024年销售额达创纪录的100亿欧元,巩固全球市场地位 Finance

Sonae 报告2024年销售额达创纪录的100亿欧元,巩固全球市场地位

(SeaPRwire) - PORTO, Portugal, March 24, 2025 — Sonae (Euronext Lisbon: SON),这家总部位于葡萄牙的跨国集团在关键领域拥有领先的市场地位,宣布了2024年全年的创纪录财务业绩。由于零售业务市场领导地位的加强、持续的内生增长以及战略收购,该集团的收入增长了18%,达到99.5亿欧元。 EBITDA也大幅增长,超过10亿欧元,而归属于股东的净利润在可比基础上增长了18%,达到2.23亿欧元。该集团的投资达到了历史性的15.89亿欧元——是前一年的两倍多——支持了战略收购和内生扩张。 “2024年对于Sonae来说是非常棒的一年,我完全相信我们有基础在未来取得更大的成功” Sonae的CEO Cláudia Azevedo说。“扩大我们的投资组合并加强我们的核心业务,促使我们达成了两个重要的里程碑:集团销售额达到约100亿欧元,同比增长18%,EBITDA超过10亿欧元。投资经过战略管理,以支持价值创造机会,包括增强我们的数字化能力、扩展我们的业务以及执行关键的投资组合调整,” Cláudia Azevedo总结道。 Sonae 在其对可持续增长和长期价值创造的承诺方面继续取得稳固进展。2024年,该集团86%的长期融资额度与可持续、绿色或ESG绩效标准挂钩。与2022年相比,运营二氧化碳排放量减少了19%,自有品牌产品的可回收塑料包装达到90%。 社区支持也增加了,在以食物捐赠和教育为重点的倡议中投资了3400万欧元。多样性仍然是优先事项,目前女性占据41%的领导职位。此外,Sonae 提议每股派发 5.921 欧元分的股息,反映出 6.5% 的股息收益率和 52% 的集团合并净利润的派息率。 The Sonae group comprises: 葡萄牙领先的食品零售连锁店,拥有1000多家门店和450万活跃的会员卡会员。 伊比利亚半岛最大的健康、保健和美容零售运营商,拥有800多家门店,年收入达15亿欧元。 葡萄牙领先的电子产品零售商,通过其不断增长的技术维修服务网络扩大其在欧洲的业务。 一家国际房地产专家,共同控制着拉丁美洲最大的购物中心运营商。 葡萄牙第二大电信提供商,引领该国5G部署。 一家活跃的科技投资者,拥有价值3.23亿欧元的高科技投资组合。 Sonae 在 Euronext Lisbon 上市,拥有超过 57,000 名员工,并拥有六十年的负责任增长的传统,这已获得 S&P Global Sustainability Yearbook 的认可、其强大的 CDP 评级以及其在 Bloomberg Gender-Equality Index 中的上市。其使命仍然是创造长期经济和社会价值,将进步和创新的益处带给越来越多的人。 Find out more at Logo – 本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More
受监管的区块链:高效金融业的基础 Finance

受监管的区块链:高效金融业的基础

(SeaPRwire) - 尼日利亚拉各斯, 2025年3月24日 — 全球金融格局正处于十字路口。虽然数字金融服务带来了便利性和可访问性,但它们也带来了新的挑战——从监管不确定性到跨境交易效率低下,再到fraud风险,同时由于高成本,仍然限制了许多人的负担能力。一份开创性的白皮书,Regulated Blockchain: Infrastructure for regulated DeFi: Foundation for a golden age in finance,由金融科技远见家Obi Emetarom撰写,提出了一个变革性的框架,解决了这些问题,并为受监管的价值互联网铺平了道路——一个由区块链驱动的金融生态系统,将创新与合规无缝集成。 传统金融 (TradFi) 仍然受到高成本、繁琐流程和监管复杂性的困扰。根据World Bank的数据,2023年全球汇款费用平均为6.2%,远高于联合国可持续发展目标 (SDGs) 设定的3%目标,这使得全球数百万人的交易成本高昂。与此同时,基于crypto的decentralized金融 (DeFi) 一直在信任、采用和监督方面挣扎。仅在2023年,根据 的数据,与crypto相关的黑客攻击和fraud造成的损失就超过$1.8 billion,突显了对更安全和受监管的方法的需求。 该白皮书认为,Regulated Blockchain Infrastructure 是缺失的一环,它提供了一个安全、高效和透明的基础,结合了两者的优点。Regulated Blockchain 是一种使用区块链技术实现金融服务创新民主化,同时执行金融监管机构制定的明确规则并实现实时监督的新方法。它结合了区块链的安全性和速度,以及保证合规性、防止fraud和确保信任所需的监督。与在政府控制之外运营的cryptocurrencies不同,Regulated Blockchain 允许银行、金融科技公司和支付提供商使用区块链进行更快、更便宜和更安全的交易——所有这些都具有必要的合规性和监管监督。这意味着人们和企业可以更有效地消费、储蓄和投资资金,银行可以更有效地提供产品,监管机构可以防止非法活动,同时使每个人都能更轻松地获得金融服务。通过将监管协议直接嵌入到区块链技术中,金融机构、金融科技公司和监管机构可以解锁无摩擦的金融服务、自动化合规性和前所未有的透明度。 Obi Emetarom, the paper’s author and the CEO and co-founder of 表示:“这份白皮书是对政策制定者、金融机构和创新者的行动呼吁 。” “世界无法承受在过时的金融模式下运作。Regulated Blockchain Infrastructure 为实现金融服务安全、包容和具有普遍影响力的未来提供了明确的道路。这不仅仅是提高效率——而是重塑全球金融,使其为每个人、每个地方服务。” 该白皮书概述了 Regulated Blockchain Infrastructure 如何加速经济增长、最大限度地提高金融包容性并提高监管效率。对于中央银行和监管机构而言,它提供了一个无缝监督和风险缓解的框架,同时支持创新。对于金融科技公司而言,它提供了一条采用区块链技术的结构化途径,而不会产生监管摩擦。对于投资者和全球金融机构而言,它创造了一个透明和安全的环境,可以增强资本配置和投资机会。 与此同时,根据Atlantic Council的数据,中央银行数字货币 (CBDC) 的兴起(目前在 130 多个国家/地区进行试点)表明机构越来越多地采用基于区块链的金融解决方案。Regulated Blockchain 通过集成可编程合规性、资产自我托管和自动化金融产品来增强这种势头,从而重新定义了在全球范围内交换、存储和管理价值的方式。Obi 的最终愿景是让多个 Regulated Blockchains 互连并共同充当受监管的价值互联网,从而为未来的完全数字化和自动化经济提供动力 随着技术变革步伐的加快,现在是时候重新思考全球经济的基础了。当政策制定者、监管机构、金融机构领导者和技术创新者共同努力塑造金融服务的未来时,这份 Regulated Blockchain 白皮书为建立更高效、包容和有影响力的金融生态系统提供了路线图。 完整白皮书可用 About Obi Emetarom Obi Emetarom 是一位有远见的金融科技企业家,也是 Zone 的联合创始人兼首席执行官,Zone 是Africa’s fastest growing payment infrastructure company. 凭借二十多年在推动金融技术创新方面的经验,Obi 一直站在构建变革性解决方案的最前沿,这些解决方案弥合了传统金融和decentralized系统之间的差距。从率先推出Africa’s first Banking SaaS platform 到推出非洲大陆首个受监管的区块链支付网络,他的工作重塑了金融服务行业。 SOURCE Regulated Blockchain本文由第三方内容提供商提供。SeaPRwire (https://www.seaprwire.com/)对此不作任何保证或陈述。 分类: 头条新闻,日常新闻 SeaPRwire为公司和机构提供全球新闻稿发布,覆盖超过6,500个媒体库、86,000名编辑和记者,以及350万以上终端桌面和手机App。SeaPRwire支持英、日、德、韩、法、俄、印尼、马来、越南、中文等多种语言新闻稿发布。
More

Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO’s Growth Momentum Strong

HONG KONG, Mar 25, 2025 - (ACN Newswire via SeaPRwire.com) - CanSino Biologics Inc. (Stock Code: 688185.SH, 6185.HK, "CanSinoBIO" or the “Company”), a leading player in China's vaccine industry, achieved significant revenue growth in 2024, driven by continuous R&D innovation and strong commercial capabilities.In 2024, CanSinoBIO reported a total revenue of RMB 846 million, marking a 137.01% year-on-year increase. This remarkable growth signifies the initial success of the company’s transformation from a Biotech to a Biopharma company. With multiple blockbuster products advancing in its pipeline, ongoing technological breakthroughs, and the expansion of its international business landscape, CanSinoBIO is poised for continuous growth momentum in 2025.In 2024, CanSinoBIO’s core product, the MCV4 (Menhycia®, the Group ACYW135 Meningococcal Conjugate Vaccine (CRM197)), the only quadrivalent meningococcal conjugate vaccine in China, has rapidly achieved market penetration under its unique "direct sales + CSO" distribution model. This result validated the feasibility of its commercial strategy, empoweing MCV4 as a stable revenue contributor to the company. As the only domestically approved product, Menhycia® has secured multiple regulatory approvals and certifications in overseas markets such as Indonesia, the Middle East, and South America. Notably, its Halal certification granted in Indonesia enables access to the global Muslim market, which comprises over 1.8 billion people. The gradual execution of the overseas strategy, combined with the expansion of MCV4’s target population, is expected to significantly increase the company’s revenue base.In addition to the strong performance of its core product, multiple positive results are expected in CanSinoBIO's product pipeline. , with several innovative products expected to be launched within the next two years.The Company’s pioneering PCV13i [13-valent pneumococcal conjugate vaccine (CRM197, TT Vector)], featuring the innovative CRM197+TT dual-carrier technology, has completed pre-market inspections and is expected to receive approval in 2025. This vaccine is designed to significantly enhance children's immunity against prevalent pneumococcal serotypes, effectively preventing infections caused by pneumococci. Compared to other single-vector vaccines, the dual-vector technology used in this vaccine effectively reduces the risk of immune interference caused by excess amount of the same carrier protein, and minimizes the suppression of immunogenicity when co-administered with other vaccines. Additionally, the design and production processes of this vaccine have been improved. Clinical studies have shown that it effectively induces high levels of specific antibodies against multiple serotypes that pose significant risks to children in China. With its technological advantages, this vaccine is set to stand out in the competitive pneumococcal vaccine market, potentially securing a strong market position and becoming a new growth driver for CanSinoBIO.CanSinoBIO is also advancing its absorbed diphtheria, tetanus and acellular pertussis (components) combined vaccine for full age-range coverage. The company's DTcP for infants and young children was officially included in the priority review list, positioned as a domestic alternative to imported products. CanSinoBIO has also developed a Tdcp for people aged 6 years old and above, which is currently in Phase II/III clinical trials and completed Phase III participant enrollment. Furthermore, in February 2025, CanSinoBIO's globally pioneering DTcP-Hib-MCV4 Combined Vaccine received clinical trial approval in China. This innovative vaccine integrates DTcP, Hib, and meningococcal vaccines, significantly reducing the required number of vaccinations. Upon launched to market, it is expected to become a benchmark product in the multivalent/combination vaccine sub-sector.CanSinoBIO is not only expanding its core products in international markets but also actively fostering collaborations with overseas partners. In 2024, the Company reached partnership with the National Institutes of Biotechnology Malaysia (NIBM) to develop multivalent mRNA influenza vaccine. This initiative represents Malaysia’s first venture into mRNA vaccine development, supporting the country to build its capabilities in this area, while advancing CanSinoBIO’s overseas strategy and enhancing the branding value of its innovative vaccine. CanSinoBIO also signed a strategic Memorandum of Understanding (MoU) with Butantan Institute, Brazil’s largest vaccine manufacturer, with the aim of jointly promoting the development of innovative vaccines and mRNA technology. This partnership further strengthens the bilateral collaboration in promoting public health and establishes global partnerships for the Company.Additionally, the Company received over US$17 million in funding from the Bill & Melinda Gates Foundation to advance its recombinant poliovirus vaccine (“VLP-Polio”) project. This funding also supports related combined vaccine candidates. The VLP-Polio vaccine is a non-infectious vaccine that does not rely on live viruses. This innovative approach may provide a superior safety profile with equivalent or better immunogenicity, earning a recommendation from the World Health Organization as a key tool in the future eradication of polio, particularly in the post-eradication era.From the successful commercialization of its flagship MCV4 vaccine to its rapidly expanding pipeline and steady progress in international expansion, CanSinoBIO is deeply engaging in the global vaccine industry with "China-led innovation." Looking ahead, CanSinoBIO is well-positioned to achieve even greater breakthroughs in commercialization, contributing to global public health and dedicating its vital role in preventing diseases all around the world. Copyright 2025 JCN Newswire via SeaPRwire.com.
More

收入狂飙同比增长137% 多款产品蓄势以待 康希诺增长动能充沛

香港, 2025年3月25日 - (亚太商讯 via SeaPRwire.com) - 康希诺生物股份公司(股份代码:688185.SH和6185.HK,以下简称:康希诺)作为中国疫苗领域的佼佼者,凭借持续的研发创新和强大的商业化能力,在2024年实现了显著的业绩增长。康希诺在2024年实现营业总收入8.46亿元,同比增加137.01%,这一突破标志着公司从Biotech向Biopharma的转型初见成效。而随着后续多款重磅产品的不断推进、技术管线的持续突破以及国际化布局的逐渐深化,康希诺在2025年有望迎来更强劲的增长动能,2024年,康希诺的核心产品MCV4疫苗(曼海欣®)作为中国唯一四价流脑结合疫苗,在"自营团队+CSO推广商"的营销模式赋能下,实现了快速市场渗透,验证了其商业模式的可行性,成为公司业绩的稳定基本盘。作为国内独家产品,曼海欣®在印尼、中东、南美等海外市场接连取得注册与认证突破,尤其是Halal认证的获批,为其打开了全球超18亿人口的穆斯林市场。国际化战略的逐步落地,叠加MCV4的覆盖人群拟进一步扩大,公司的收入基数有望得到显著提高。除了核心产品表现优异,康希诺的产品管线也进入密集收获期,多款产品预计将会在今明两年内上市,业绩蓄势待发。公司首创CRM197+TT双载体技术的13价肺炎结合疫苗(PCV13i)目前已完成上市前检查,预计于2025年内获批。这一疫苗将显著增强儿童对流行肺炎球菌血清型的免疫力,有效预防肺炎球菌引起的感染性疾病。与传统单载体疫苗相比,该疫苗采用的双载体技术能够有效减少大量使用同一种载体蛋白造成免疫干扰的可能性,与其他疫苗共注射时,也能减少对免疫原性造成的抑制。此外,该疫苗结合设计和生产工艺皆改良过,临床研究中显示,针对中国儿童群体中危害较严重的多种血清型,能够有效诱导较高的特异性抗体水平。凭借技术优势,该疫苗有望在竞争激烈的肺炎疫苗市场中脱颖而出,占据技术制高点,成为公司未来新的增长点。而康希诺在组分百白破疫苗上的管线布局同样具有显著的技术领先性,有望实现全年龄段覆盖。公司的婴幼儿用吸附无细胞百(组分)白破联合疫苗(婴幼儿用DTcP)已于2025年2月正式纳入优先审评品种,定位为进口替代。而在该款疫苗的基础上,公司还进一步研发了青少年及成人用吸附无细胞百(组分)白破联合疫苗(青少年及成人用Tdcp),目前已启动II/III期临床试验,并完成Ⅲ期临床试验受试者入组。值得一提的是,公司的吸附无细胞百(组分)白破b型流感嗜血杆菌(结合)-ACYW135群脑膜炎球菌(结合)联合疫苗(DTcP-Hib-MCV4联合疫苗)已于2025年2月获批临床。这款全球首创的"五联苗"将百白破、Hib和流脑疫苗整合,可大幅减少接种次数,未来上市后或成为多联多价疫苗领域的标杆产品。在海外业务中,康希诺除了推进核心产品MCV4疫苗等进入海外市场外,还积极推进与海外机构在技术方面的交流。2024年,公司与马来西亚国立生物技术研究院(NIBM)确立合作,推进mRNA多价流感疫苗研发。该项目是马来西亚首个mRNA疫苗研发项目,助力马来西亚建立mRNA疫苗开发能力,同时也有助于进一步推动公司海外战略,提升公司创新疫苗品牌价值。同年,公司还与巴西最大的疫苗制造商巴西布坦坦研究所(Butantan),正式签署战略合作谅解备忘录,旨在共同推动创新疫苗及mRNA技术的发展,深化中巴两国在公共卫生领域的合作,构建全球伙伴关系。可以看到,从核心产品MCV4的成功商业化,到丰富的后续产品管线,再到国际化战略的稳步推进,康希诺正以"中国创新"深度参与全球疫苗产业链。展望未来,康希诺有望在国内外市场实现更大的突破,为全球公共卫生事业持续贡献力量,为全球疾病防控体系注入中国动能。 Copyright 2025 亚太商讯 via SeaPRwire.com.
More
Wintermar Reports Results For The Full Year Ended 31 December 2024 ACN Newswire

Wintermar Reports Results For The Full Year Ended 31 December 2024

SINGAPORE, Mar 24, 2025 - (ACN Newswire via SeaPRwire.com) - Wintermar’s Operating Profit jumped by 101.5%YOY to US$17.8 million on the back of a 13.5%YOY increase in Total Revenue to US$82.4million, from higher charter rates and a better fleet mix of DP (Dynamic Positioning) vessels.Owned Vessel DivisionOwned Vessel Revenue rose by 28.9%YOY to US$62.1million for FY2024 from US$48.2million in FY2023. This was driven by a larger number of DP vessels in the fleet which pushed the average charter rates for 2024 up by 26% as compared to the average charter rate in 2023. These factors contributed to a 106.2%YOY jump in Gross Profit from Owned Vessels to US$22.4million for FY2024 with vessel utilization in 2024 at 66%, slightly lower than 68% for 2023.Owned Vessel gross margin has increased to 36.1% in FY2024 as compared to 22.6% in FY2023, reflecting a strong increase in charter rates as well as a better fleet exposure to the DP segment. Our 5150BHP to 8000BHP AHTS as well as PSVs experienced a higher charter rate boost than the rest of the fleet due to rising demand for deeper water drilling projects, which require DP capability.Vessel utilization fell in 4Q2024 to 63% compared to 67% in 3Q2024. Some vessels completed spot contracts while the monsoon season in Brunei also impacted utilization. These vessels underwent maintenance and will start operations again in mid 1Q2025. The additional PSV which was delivered in October 2024 did not commence operations until January 2025. Chartering Division and Other ServicesGross Profit from Chartering rose by 28.7%YOY to US$1.4million, despite slightly lower revenue of US$13.7million, reflecting improved margins. Gross Profit from Other Services recorded a decline of 16.7%YOY to US$2.6million upon the completion of a contract. Total Revenue for FY2024 rose 13.5% YOY to US$82.4 million with Total Gross Profit of US$26.4 million (+75.5%YOY) for FY2024 as compared to Total Revenue of US$72.6 million and Total Gross Profit of US$15.0 million in FY2023.Direct Expenses and Gross ProfitOwned Vessel Direct expenses rose by 6.4% YOY to US$39.7million, largely from higher maintenance costs, which rose by US$7.5million (+21.8%YOY), in additional to higher crewing costs of US$10.3million (+10.5%YOY).The higher maintenance and crewing costs are aligned with operating a fleet of higher value vessels and a larger proportion of operations outside of Indonesia. Depreciation costs rose by 5.4%YOY to US$13.4million as the number of operational vessels increased. Bunker costs rose by 7.2%YOY to US$3.3million due to higher oil prices and a larger number of vessels mobilized in and out of Indonesia.Indirect Expenses and Operating ProfitIndirect Expenses rose by 38.5%YOY to US$8.6million, with Staff Salary contributing US$1million to the increase, reflecting a focus on strengthening the operations, technical and IT teams to manage a higher value fleet, as well as the payment of employee bonuses in line with the strong operational performance. As the Company now participates in more international tenders, there has been an increase in marketing expenses by 164.8%YOY to US$0.66million.Operating margins jumped to 21.6% for FY2024 compared to 12.2% in 2023, as Operating Profit doubled to US$17.8million for FY2024, reflecting the impact of operational gearing on the Company’s profitability as charter rates begin to rise.Other Income, Expenses and Net Attributable ProfitInterest Expenses and financial charges fell by 4.2%YOY to US$1.2million while interest income rose by 582%YOY to US$0.46million, as the Company continued to accumulate cash flow and pay down debt. Equity in net earnings of associates jumped to US$2.4million for FY2024 from US$0.55million in FY2023, with strong contribution from associated companies with OSV operations which also benefitted from the strong industry upturn.The sale of fixed assets contributed a one-off gain of US$16.1million, largely from the sale of an older PSV in the first half of 2024. Due to the strengthening of the A, the Company recorded a FX loss of US$0.47million mainly from Rupiah denominated trade receivables.Non-controlling interest was significantly higher at US$9.8million compared to a small loss of US$0.04million in FY2023. The largest contributor to this was from the gain on sale of fixed asset as well as the stronger earnings from the PSV business which is 51% controlled by Wintermar.Net Attributable Profit to shareholders for FY2024 was US$22.5million, a significant jump of 237% compared to US$6.7million in FY2023. Excluding the gain on sale of Vessel, the underlying core profit increased by 126.5%YOY to US$15.1million compared to US$6.6 million in FY2023.FY2024 EBITDA increased by 44.8% YOY to US$31.5million.Industry OutlookThe recent months have been characterized by rising global uncertainty arising from dramatic policy changes in the US, the prospect of tariff wars and the fragile ceasefire in Gaza. These upheavals have not derailed the underlying momentum in the upstream investment cycle, which seems to still be unfolding as major oil companies have started to roll back renewable energy projects in favour of investing in oil and gas. The oil price has corrected from previous highs but is forecasted to stay firm in the next couple of years from OPEC+ intervention.In Indonesia, the government remains committed to the various major deepwater projects which have received investment approval in the past 12 months. SE Asian charter rates corrected slightly at the end of 2024 after a very sharp spike up in the past 12 months. However, there are several Engineering Procurement (EPCI) projects which require OSV for short-term projects, which accounts for a more volatile utilization of the OSV fleet. Business ProspectsDespite a slower 4Q2024, we are still optimistic on the outlook for OSVs in Indonesia as there are several approved deepwater drilling projects particularly in the Makassar strait and the Andaman sea which are likely to commence in 2H2025 to 2026. Some EPCI contracts have been awarded and tendering for the marine spread is ongoing for 2H2025 commencement. All this points to continued short term contracts, by virtue of where we are at this early stage of the drilling cycle, and we expect continued volatility in utilization rates while charter rates should remain firm.Wintermar took delivery of 3 units of newbuilt Heavy Load Barges (HLB) between December 2024 to February 2025. The vessels are in the process of conversion to Indonesian flag and will be ready to work by 2Q2025. In addition, the Company has ordered a newbuilt Platform Supply Vessel for delivery in 2026, which will enhance the DP capability of the fleet and reduce average age of the fleet. These acquisitions have been funded through internal cash flow and will be refinanced upon delivery. In 2H2025, another reactivated PSV is expected to be operational, adding to our capacity for 2025.Contracts on hand as at end February 2025 amounted to US$66million. About Wintermar Offshore Marine GroupWintermar Offshore Marine Group (WINS.JK), developed over nearly 50 years with a track record of quality that is both a source of pride and responsibility that we are dedicated to upholding, and sails a fleet of more than 48 Offshore Support Vessels ready for long term as well as spot charters. All vessels are operated by experienced Indonesian crew, tracked by satellite systems and monitored in real-time by shore-based Vessel Teams.Wintermar is the first shipping company in Indonesia to be certified with an Integrated Management System by Lloyd's Register Quality Assurance, and is currently certified with ISO 9001:2015 (Quality), ISO14001:2015 (Environment) and OHSAS 18001:2007 (Occupational Health and Safety). For more information, please visit www.wintermar.com.For further information, please contact:Ms. Pek Swan Layanto, CFAInvestor RelationsPT Wintermar Offshore Marine TbkTel (62-21) 530 5201 Ext 401Email: investor_relations@wintermar.com DISCLAIMERCertain statements made in this publication involve a number of risks and uncertainties that could cause actual results to differ materially from those projected. Certain statements relating to business and operations of PT Wintermar Offshore Marine Tbk and Subsidiaries (the Company) are based on management’s expectations, estimates and projections. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Certain statements are based upon assumptions as to future events that may not prove to be accurate. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such statements. The Company makes no commitment, and disclaims any duty, to update or revise any of these statements. This publication is for informational purposes only and is not intended as a solicitation or offering of securities in any jurisdiction. The information contained in this publication is not intended to qualify, supplement or amend information disclosed under corporate and securities legislation of any jurisdiction applicable to the Company and should not be relied upon for the purpose of making investment decisions concerning any securities of the Company. Copyright 2025 ACN Newswire via SeaPRwire.com.
More
Dida Inc. (02559.HK) Announced 2024 Annual Results, RMB 211 Million Adjusted Net Profit ACN Newswire

Dida Inc. (02559.HK) Announced 2024 Annual Results, RMB 211 Million Adjusted Net Profit

HONG KONG, Mar 24, 2025 - (ACN Newswire via SeaPRwire.com) - Dida Inc. (“Dida” or the “Company”, Stock Code: 02559.HK), a leading technology-driven mobility platform, announced the audited consolidated annual results for the year ended December 31, 2024.Financial Highlights:- Revenue was RMB787.2 million for the year ended December 31, 2024, compared to RMB815.1 million for the year ended December 31, 2023.- Gross profit was RMB567.0 million for the year ended December 31, 2024, compared to RMB605.4 million for year ended December 31, 2023.- Net profit increased by 234.4% from RMB300.4 million for year ended December 31, 2023 to RMB1,004.3 million for the year ended December 31, 2024.- Adjusted net profit (non-IFRS measure) was RMB211.4 million for the year ended December 31, 2024, compared to RMB225.6 million for the year ended December 31, 2023.Operation Highlights:- Gross transaction value amounted to RMB7.4 billion and total number of orders reached 119.1 million for the year ended December 31, 2024.- Registered users reached over 372 million as of December 31, 2024- Certified private car owners reached 18.9 million, an increase of 21.4% year-on-yearBusiness OutlookCarpooling marketplace businessThe Company believes carpooling in China is still at its early stage of development, with significant market demand yet to be fully released and the benefits of carpooling not fully recognized by the public. At the same time, the Company notices a year-on-year increase in the demand for carpooling. In 2024, the number of passengers who placed orders surged 34.3% year-over-year, driven by robust demand in lower tier cities. Riders on the platform can access low-cost mobility options and enjoy quality experience. Private car owners can save money on gas and tolls by sharing traveling expenses with riders. Carpooling also brings about numerous societal benefits, such as reducing carbon emissions and mitigating traffic congestion. In the future, the Company will seek more robust, healthier, and suitable transportation capacity and a broader user base through multiple approaches. The Company will establish strong collaborations with third-party platforms to expedite the growth initiatives. In the lower-tier cities, the Company will drive growth through the conversion of private domain traffic, the dissemination of a “low-price” mindset, and the optimization of mini-program functionalities. The Company will continue to fine-tune the algorithms for precise route matching to enhance driver retention. Furthermore, the Company will explore various scalable carpooling scenarios, such as employee commuting and student travel to and out of college campuses, to expand the user base. For the driver side, the Company will also encourage more diversified demands to provide better travel experiences, especially for those looking for better ride compatibility. Moving forward, the Company will continue to refine the station based carpooling model to better meet user needs by offering more compatible and cost effective options.Taxi businessIn selected cities where the Company has already entered into strategic cooperation agreements, the Company will closely work with all relevant stakeholders, including local authorities, taxi industry associations, taxi companies, and taxi drivers to implement its strategy for smart taxi services. Several cities are considering changing traditional fixed-price models for taxi riding to dynamic pricing in response to competition from ride-hailing. The Company is leveraging this opportunity to provide smart taxi service solutions tailored to these cities, which includes technologies and systems to support the implementation of dynamic pricing.For the full announcement of Dida for the annual results ended December 31, 2024, please visitt: https://manager.wisdomir.com/files/594/2025/0321/20250321213001_91138480_en.pdfAbout Dida Inc.Dida Inc. (“Dida” or the “Company”, Stock Code: 02559.HK) is a leading technology-driven mobility platform in China. The Company creates more transit capacity with less environmental impact by providing carpooling marketplace services to pair up riders with private car owners if they are heading in similar directions at compatible times. It also provides smart taxi services, aiming to improve the efficacy and efficiency of relevant stakeholders in the taxi industry in China. Dida makes the mobility ecosystem greener and more efficient, and each trip experience warm and enjoyable.Forward-Looking StatementsThis press release contains forward-looking statements relating to the business outlook, forecast business plans and growth strategies of the Company. These forward-looking statements are based on information currently available to the Company and are stated herein on the basis of the outlook at the time of this press release. They are based on certain expectations, assumptions and premises, some of which are subjective or beyond the control. These forward-looking statements may prove to be incorrect and may not be realized in future. Underlying the forward-looking statements is a large number of risks and uncertainties. Further information regarding these risks and uncertainties is included in the other public disclosure documents on the corporate website. Copyright 2025 ACN Newswire via SeaPRwire.com.
More
Q P Group’s Net Profit Surges 61% to HK$129 Million in 2024 ACN Newswire

Q P Group’s Net Profit Surges 61% to HK$129 Million in 2024

HONG KONG, Mar 24, 2025 - (ACN Newswire via SeaPRwire.com) - Q P Group Holdings Limited (“Q P Group” or the “Group”; Stock code: 1412), a paper product manufacturing and printing services provider, today announced its annual results for the year ended 31 December 2024 (“FY2024” or the “Reporting Period”).In FY2024, the Group achieved revenue of approximately HK$1,210.9 million, representing a year-on-year increase of approximately 16.5%, driven by increased demand from its original equipment manufacturer (“OEM”) and web sales customers. Bolstered by continuous improvements in operational and production efficiency, profit attributable to the equity holders of the Company surged approximately 61.2% to approximately HK$129.1million.The Board of Directors has proposed a final dividend of HK11.0 cents per share (FY2023: HK8.0 cents) for FY2024. Together with the interim dividend of HK3.0 cents (FY2023: HK2.0 cents) already paid, the total dividend for FY2024 will be HK14.0 cents per share (FY2023: HK10.0 cents).Business ReviewDuring the Reporting Period, the Group remained highly focused on steady business expansion and optimisation of operations, successfully capturing new business opportunities driven by rising demand for its major OEM customers’ products. Additionally, the Group made steady progress in diversifying its business across various product lines. Leveraging strengths in product development, production know-how and operation standards for trading cards production, it cultivated business relationships with an industry-leading global trading card company and various publishers in China. During the Reporting Period, the Group’s OEM sales reached approximately HK$984.8 million, up approximately 16.4% from approximately HK$845.8 million for FY2023.In terms of web sales business, riding on the well-established market position, enhanced customer experience and effective cost-saving measures, the Group’s web sales achieved steady growth during the Reporting Period. Q P Market Network (“QPMN”), our recently launched business-to-business-to-consumer (B2B2C) e-commerce platform, also made ongoing efforts to enhance its website’s infrastructure and functionality, and successfully built relationships with business partners from all over the world. In FY2024, the Group’s web sales amounted to approximately HK$226.1 million, representing a growth of approximately 16.9% as compared with approximately HK$193.4 million for FY2023.In respect of operations, the Vietnam plant commenced full-scale operations during the Reporting Period, becoming a crucial production hub for the Group. In September 2024, the Group entered into a construction agreement with a contractor for the construction works in relation to the expansion of the Vietnam plant.ProspectsLooking ahead, the Group will stay focused on steady business expansion and operational optimisation. It aims to strengthen its OEM solutions by innovating in product structural design, printing and finishing techniques, and new material utilisation. To capitalise on the booming trading card games market, the Group will actively participate in relevant trade shows to enhance market penetration and position itself to seize emerging opportunities.The development of QPMN remains the Group’s key growth strategy in web sales business in the long run. The Group will focus on enriching its e-commerce solutions for product customisation, expanding its product range and enhancing its integration with popular e-commerce platforms, in order to better align with the market standard and expectations of business partners. For the Original Brand Manufacturer (“OBM”) business, the brand’s dedicated team has formulated a series of online and offline approaches, aiming to progressively diversify the brand’s sales channels, enlarge customer base, broaden market presence and grow the customer base. Besides playing cards, the brand will explore the market potential of other products such as trading card games, board games, and tarot decks to promote brand awareness and expand revenue streams.The Group will continue to optimise production operations, with the expansion of its Vietnam production base progressing on schedule and expected to commence operations in the third quarter of 2025. This strategic expansion will enable the Group to develop a more comprehensive supply chain in Vietnam and diversify the potential operational risks arising from geopolitical factors. On the other hand, following the recent milestone of achieving the certification of 2i level of Industry 4.0 maturity, the Group is committed to advancing its digital transformation through improvement in utilisation of operational data and scaling up the application of smart operations across more production lines and workshops.Mr. Cheng Wan Wai, Founder, Chairman and CEO of Q P Group concluded: “The manufacturing industry is predicted to face a complicated economic landscape with both opportunities and challenges in 2025. The consumer market is expected to show resilience, underpinned by steady economic growth and declining inflation. In contrast, the imposition of tariffs and heightened protectionism driven by widespread geopolitical tensions will inevitably impact the manufacturing sector. Based on our solid business and financial foundation, we are confident about the long-term prospect of the Group. We will continuously implement appropriate strategies to sustain steady growth and create long-term value for our stakeholders.About Q P Group Holdings Limited (Stock code: 1412)Established in Hong Kong in 1985, Q P Group is one of the leading paper-based tabletop games and greeting cards manufacturers in the PRC, with production sites in Dongguan and Heshan in Guangdong Province and Phu Ly City in Ha Nam Province, Vietnam. Its principal product categories include tabletop games, greeting cards, trading cards, educational items and premium packaging. Since 2010, the Group has been operating web sales businesses to provide online solutions for diversified customised paper products and gift items. Currently, the number of its active registered users has reached over 77,600.Q P Group’s major websites are:www.makeplayingcards.comwww.boardgamesmaker.comwww.createjigsawpuzzles.comwww.printerstudio.comQ P Market Network:www.qpmarketnetwork.comFor more information, please visit: https://www.qpp.com/Media EnquiriesStrategic Financial Relations LimitedVicky LeeTel: (852) 2864 4834Email:vicky.lee@sprg.com.hkPhoebe LeungTel: (852) 2114 4172Email:phoebe.leung@sprg.com.hkWill ChengTel: (852) 2864 4894Email:will.cheng@sprg.com.hkWebsite: http://www.sprg.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com.
More
DEXIS to Showcase Cutting-Edge Innovations at IDS 2025 ACN Newswire

DEXIS to Showcase Cutting-Edge Innovations at IDS 2025

QUAKERTOWN, PA, Mar 24, 2025 - (ACN Newswire via SeaPRwire.com) - DEXIS, the global leader in dental imaging technologies, is excited to announce its participation in the International Dental Show (IDS) 2025 in Cologne, Germany.The company will showcase new technologies within the DEXIS digital ecosystem, an AI-powered platform that connects each step of the digital workflow, from diagnosis to delivery. The ecosystem combines AI, 2D & 3D imaging, intraoral scanning, diagnostics, and treatment planning to create one integrated solution that streamlines processes and boosts productivity."We're excited to give IDS attendees the very first look at some of our new technologies," says DEXIS President, Robert Befidi. "All of our innovations are designed to improve patient interactions and make dental practices more effective and efficient. We're eager to put our products into the hands of dental professionals and demonstrate the capabilities of our new technologies."Among these innovations are some exciting updates to the DEXIS intraoral scanning portfolio. Visitors will get an exclusive first look at the company's all-new intraoral scanner under development, Imprevo. With a sleek new design, fully rebuilt hardware, and AI-powered algorithm, Imprevo will become the new high-performance flagship of the DEXIS IOS portfolio.IS ScanFlow, the software that powers the DEXIS intraoral scanner line, will preview its newest version, IS ScanFlow 2.0, featuring a new Smile Visualizer tool. The tool will allow dental professionals to show patients a realistic preview of their smile before and after treatments, helping them to visualize and better understand treatment recommendations.DEXIS will also unveil updates to the ORTHOPANTOMOGRAPH™ OP 3D™ EX, which will soon include cephalometric imaging capabilities. The new ceph modality, which features the company's patented ORTHOceph™ Plus design, will provide necessary protocols such as lateral and pediatric lateral projections, posterior-anterior projections and carpus imaging* - all with fast scan times and at a limited dose.Additionally, the DEXIS 3D imaging portfolio will introduce an Automatic Dose Control feature for the ORTHOPANTOMOGRAPH™ OP 3D™ LX. The feature will measure patients' anatomy and automatically set exposure levels for optimal image quality and dose. Early adopters have reported positive feedback:"The new Automatic Dose Control is one of the few things in life I don't have to question," says Dr. Katya Archambault of San Diego Health Center. "It offers both better and more consistent image quality. I could never argue with the results."Also being showcased are new features within DTX Studio™ Clinic, the core software of the DEXIS digital ecosystem. Known for its comprehensive integration of all modalities of patient data, DTX Studio Clinic streamlines diagnostics, patient education, treatment planning, and surgical guide generation.The software's new features include a suite of tools designed to streamline the implant treatment planning process. Users can now plan an implant treatment and generate an automated surgical template chairside in under 3 minutes. Additionally, the software introduces an Assisted Implant Planning module that automates initial implant positioning, and a Face Scan tool that integrates facial scans with 3D X-rays, further enhancing the planning process.Attendees will also get the chance to preview new innovations, set to be released in future updates of DTX Studio Clinic. Among these innovations is a new, AI-driven endodontic capability, that will provide 3D visualizations of root canals, enhancing diagnostic accuracy and treatment efficiency. Additionally, updates to the focus areas detection tool will be showcased, enhancing the visualization of teeth in intraoral X-rays and detecting eight additional dental findings.DTX Studio Clinic will also introduce a new Cloud-based solution that will allow clinicians to connect their practices and consolidate data in one place. This feature is designed to enhance collaboration and streamline workflows, ultimately improving practice efficiency and patient outcomes. These advancements showcase the future of dental technology, making DTX Studio Clinic an integral part of modern dentistry.DEXIS invites all IDS attendees to visit Hall 11.2 K050 L069 to experience the innovations that DEXIS has to offer. Their team of experts will be ready to provide demonstrations and answer questions.With more than 165,000 solutions in use around the world, DEXIS continues to set the standard for quality and reliability in dental imaging. For more information about DEXIS and its participation in IDS, please visit DEXIS @ IDS 2025.About DEXISDEXIS is the global leader in dental imaging. We bring together the most trusted brands in 2D and 3D imaging, intraoral scanning solutions, and diagnostic software, in one connected and AI-powered ecosystem. Our innovative and award-winning technologies use smart simplicity to increase productivity and enhance diagnostic confidence. For more information, please visit DEXIS.com.About EnvistaEnvista Holdings Corporation is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Its comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide array of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry. For more information, please visit www.envistaco.com.DXIS01006/Rev00*Carpus is an optional imaging programContact InformationMaria PenalozaMedia & Content Strategy Managermariap@accessnewswire.comMichelle CabralSenior Marketing Director, DEXISmichelle.cabral@envistaco.comSOURCE: Envista Copyright 2025 ACN Newswire via SeaPRwire.com.
More

ENTERPRISE DEVELOPMENT HOLDINGS LIMITED ANNUAL RESULTS FOR THE YEAR 2024

Financial Highlights- Revenue was RMB408,585,000, representing an increase of 574% year-on-year;- Gross profit was RMB46,014,000, representing an increase of 77% year-on-year;- Net profit was RMB73,561,000, representing an increase of 1,835% year-on-year;- Closing cash and cash equivalents was approximately RMB160,575,000.HONG KONG, Mar 24, 2025 - (ACN Newswire via SeaPRwire.com) - Enterprise Development Holdings Limited (“Enterprise Development Holdings” or the “Company”, stock code: 1808.HK) announced the consolidated financial results of the Company and its subsidiaries (collectively referred to as the “Group”) for the year ended December 31, 2024 (the “Reporting Period”).In 2024, driven by emerging sectors such as artificial intelligence, digital industry of China maintained stable overall operations, with further enhancements in innovation capabilities. The pace of enterprises going global accelerated, continuously accumulating new momentum and advantages. The Group actively seized industry development opportunities, led with innovation and made steady progress. The Group continued to steadily expand its existing business while fostering new-quality productive forces, with a focus on the digital economy sector. The Group’s business layout and development have begun to bear fruit through phased achievements.During the Reporting Period, benefiting from the continuous development of the Group’s existing business, the Group secured and completed new contracts which involved integrated IT solutions, edge computing, intelligent computing and other data services. The Group recorded the revenue of approximately RMB408,585,000, representing an increase of 574% year-on-year. Driven by the significant rise in revenue and the increase in net gains from the sale of financial assets and fair value adjustments, net profit was approximately RMB73,561,000, representing an increase of 1,835% year-on-year.BUSINESS REVIEWIn 2024, the Group adopted a business-oriented approach to accelerate the construction of the “three chains and one circle” model, continuously reinforcing an innovation-driven, open and win-win digital economy ecosystem. Meanwhile, the Group combined its technological and capital advantages in a dual-chain approach to empower various sections across the industrial ecosystem and create new engines for business growth through means such as industrial incubation and investments.In terms of capital operation, the Group has established an industrial investment fund. Through means such as industrial incubation and investments, it aims to gather more premium resources, build new engines for business growth, and further solidify its leading position in the digital economy sector. In terms of investment, in 2024, Beijing Orient Legend Maker Software Development Co., Ltd. invested 15% equity interests in Beijing Longteng Haida Technology Development Co., Ltd. to expand market penetration in PRC’s enterprise sector, leveraging its expertise in cloud-based platforms and AI-driven tools to enhance operational efficiency for their customers.During the year of 2024, the software business was benefited from the all-round improvement in management to significant growth of in the year. During the Reporting Period, the Group continued to develop its existing business, and entered into and completed new contracts which involved integrated IT solutions, edge computing, intelligent computing and other data services. The overall revenue from its software business reached RMB407,756,000, representing a year-on-year increase of 579%.OUTLOOKAmid the wave of digital transformation, digital technology is integrating into every corner of socio-economic development, becoming a crucial engine driving accelerated urban economic growth and fostering high-quality industrial advancement. In the future, the Group will capitalize on its longstanding customer resources and product and service advantages to strengthen its foundations and consolidate existing businesses. In addition, the Group will proactively position itself for the development of new-quality productive forces catalyzed by a combination of factors such as cutting-edge scientific and technological breakthroughs, innovative allocation of factors of production and industrial transformation and upgrading, particularly in the digital economy sector, promoting the integration of digital and real economy, and driving business innovation and upgrades.To actively embrace the opportunities of the digital transformation era, the Group will continue to optimize and consolidate its first-mover advantages in the fields of data elements, data asset operations, AI computing and edge computing in the future. The Group will fully unleash the agglomeration effect of the industrial chain, dedicating long-term efforts to industrial chain integration and industrial ecosystem development. Leveraging the technological potential of big data, big models and high-performance computing power, the Group is committed to establishing itself as a service provider that concentrates on the digital economy sector, with a focus on data elements, data asset operations, AI computing and edge computing, aiming to provide customers with integrated digital technology solutions and create value for our shareholders.About Enterprise Development Holdings LimitedEnterprise Development Holdings Limited (“Enterprise Development Holdings” or the “Group”, stock code: 1808.HK) is committed to establishing itself as a service provider that concentrates on the digital economy sector, with a focus on data elements, data asset operations, AI computing and edge computing, aiming to provide customers with integrated digital technology solutions.The Group will adopt a business-oriented approach to open up and establish a “three chains and one circle” model: focusing on the overall synergy of the innovation chain, industrial chain and financial chain. The Group will continue to optimize and consolidate its first-mover advantages in the fields of data elements, data asset operations, AI computing and edge computing. The Group will fully unleash the agglomeration effect of the industrial chain, dedicating long-term efforts to industrial chain integration and industrial ecosystem development. Leveraging the technological potential of big data, big models and high-performance computing, the Group will facilitate the integration of digital and real economy, continuously driving business innovation and upgrades. Copyright 2025 ACN Newswire via SeaPRwire.com.
More
CTF Life Introduces ‘GBA MediAccess’ Outpatient Insurance Plan ACN Newswire

CTF Life Introduces ‘GBA MediAccess’ Outpatient Insurance Plan

HONG KONG, Mar 24, 2025 - (ACN Newswire via SeaPRwire.com) - CTF Life announces today the launch of its “GBA MediAccess” Outpatient Insurance Plan (“GBA MediAccess” or “the Plan”), tailored for customers who travel frequently between Hong Kong, Macau, and designated Greater Bay Area (GBA) cities*. By harnessing the robust medical network of The GBA Healthcare Group (GBAH), a member of Chow Tai Fook (CTF) Enterprises, the Plan provides convenient and quality medical services. Fully leveraging CTF Group’s diverse conglomerate, CTF Life is committed to delivering quality experiences for customers and creating value beyond insurance. Notably, CTF Life has become the first insurer to partner with GBAH to offer traditional Chinese medical outpatient consultations.Three plan levels are available, covering designated GBA cities*, as well as Hong Kong and Macau. It offers market-first1 coverage for both Western and traditional Chinese medical practitioner outpatient consultations, as well as dental scaling and health management value-added services for the customer and up to two designated family members2. The Plan provides a comprehensive range of services, including online3,4 and offline general practitioner outpatient consultation3,5, with up to three days of prescribed basic medication, traditional Chinese medical outpatient consultation3,6, dental scaling3,7, and two value-added services offering proactive health management3,8 and chronic disease management3,9. This one-stop solution addresses the needs of customers and their families2 in areas ranging from health screening, continuous monitoring to health education, providing reliable, affordable, and accessible healthcare management. It sets a cornerstone for personal and family health, ensuring customers peace of mind as they travel within the GBA.CTF Life formed a strategic partnership with GBAH in early 2024, creating a tripartite alliance with the 3A hospitals in the GBA under GBAH’s network to deliver one-stop premium medical services. This collaboration not only enhances medical efficiency and reduces healthcare costs, but also elevates the customer service experience. The deepened collaboration further strengthens this partnership, actively supporting the Hong Kong SAR government’s efforts to develop the GBA by providing high-quality medical services to customers who travel frequently across the region.Jarita Kwan, Chief Product Officer of CTF Life, said: “With the rapid development of the GBA, there is a growing demand for healthcare coverage across the region. ‘GBA MediAccess’ is specifically designed to meet the evolving lifestyles of our customers and the increasing popularity of integrated Chinese and Western medical treatments. It enables customers and their families in the GBA to benefit from the CTF Group’s diverse conglomerate, accessing premium Chinese and Western healthcare services provided by GBAH. The Plan introduces market-first1 family coverage for up to three members2 to co-use services under a single plan, including Western and traditional Chinese medical outpatient services and dental scaling, fully underscoring CTF Life’s commitment to being people-focused and customer-centric. Moreover, CTF Life is the first insurer to partner with GBAH to offer Chinese medical outpatient consultations. We look forward to further strengthening our collaboration with GBAH to launch more services that cater to customer needs, creating value beyond health.”Dr. Felix Lee, Co-CEO of The GBA Healthcare Group, stated: "Our deepened collaboration with CTF Life strategically addresses evolving cross-border lifestyles and retirement needs in the GBA, while pioneering the integration of insurance and healthcare innovation. Through ‘GBA MediAccess,’ customers and their families can book appointments with internationally accredited GOLDTM-certified family doctors, accessing a suite of healthcare services. These include General Practice consultations in Guangdong, Hong Kong, and Macau, Traditional Chinese Medicine services in the GBA*, Video Consultations, Chronic Disease Management, Proactive Health Management, and the convenience of Cross-border Direct Billing for Insurance. By leveraging GBAH’s end-to-end healthcare expertise – from preventive care to treatment – our expansive cross-border network, and the region’s unparalleled medical resource advantages, we deliver multi-generational healthcare continuity across the GBA. This ensures families achieve holistic health stewardship, from preventive interventions to health legacy planning. Moving forward, building upon our professionally accredited healthcare ecosystem and trusted standards in the GBA, we will jointly propel the development of an internationally recognised value-based care model, while collaboratively pioneering innovative solutions to advance client-centered health stewardship."Key features of the Plan include:1) Market-first1 family coverage for three members:- The Plan provides coverage for the customer and up to two of their designated family members2 to take care of the family’s needs, offering comprehensive health protection and medical support in daily life.2) Online3,4 and offline general practitioner outpatient consultation services:- Regardless of whether the customer chooses a face-to-face or online consultation, the insured and designated family members2 can receive up to three days’ supply of prescribed basic medication with free delivery service (online consultations only). Three plan levels are available, with face-to-face outpatient consultation service covering designated cities in the GBA*, as well as Hong Kong and Macau.- Customers enrolled in Plan 3 can enjoy unlimited online general practitioner consultations conducted by designated clinics within the medical network, as well as medication delivery services in Mainland China10.3) Traditional Chinese outpatient consultation and dental tooth polishing services:- In addition to conventional Western medical outpatient services, upon referral by a GOLDTM doctor of GBAH, customers can receive traditional Chinese medical treatment services at designated clinics within the medical network located in designated GBA cities*. The services include consultations, diagnosis, prescribed traditional Chinese medicine for up to three days, and related traditional Chinese medical services and treatments.- The Plan also offers annual dental scaling and dental care service.4) Health management value-added services:- Proactive health management: This attentive service is conducted by GOLDTM doctors and nurses from GBAH, and includes an evaluation of a patient’s family medical history, the setting of annual health targets, education about preventive care, recommendations for a healthier lifestyle, etc. Follow-up consultations can be arranged for customers if needed.- Chronic disease management programme: GOLDTM doctors and nurses from GBAH shall offer customers and their family members education about chronic disease prevention, including regular check-ups, diabetes screening, medication management, and lifestyle advice, in a bid to achieve early prevention, early detection, and early treatment.CTF Life launches “GBA MediAccess” Outpatient Insurance Plan to enable customerswho travel frequently between Hong Kong, Macau, and designated cities in the Greater Bay Area* to receive convenient and quality medical services provided bythe robust medical network of GBAH. From left to right: Jarita Kwan, Chief ProductOfficer of CTF Life; Denise Au-Yeung, Chief Strategy Officer of CTF Life; Dr. FelixLee, Co-CEO of GBAH; and Peter Fang, Chief Insurance Officer of GBAH.Remarks:*“Designated GBA cities” refers to the six cities in Guangdong Province of the People’s Republic of China – Guangzhou, Shenzhen, Zhuhai, Foshan, Dongguan, and Zhongshan.1.“Market-first” refers to the Plan providing coverage for the customer and up to two of their family members, and it offers both Western and traditional Chinese medical practitioner outpatient consultation, as well as dental scaling and health management value-added services. “Market-first” is the result of a comparison of similar protection plans from major life insurers in Hong Kong, as of 24 March 2025.2.Family member / Designated Family Member shall be up to 2 immediate family members (i.e. Policy Owner’s legal spouse, child, or parent) designated by the Policy Owner (i.e. the Insured) at application or renewal. Designated Family Member cannot be changed within the same Policy Year. The issue age of the Insured ranges from 18 to 80 years old, while the issue age of the Designated Family Members ranges from 15 days old to 80 years old.3.For each outpatient consultation, the Insured and/or Designated Family Member is required to pay a co-payment of HKD 20 / MOP 20 / RMB 8. If the Insured and/or Designated Family Member receives any medical services, treatments, and/or medications that are not covered under this plan during any outpatient consultation or health management services provided by GBAH, the Insured and/or Designated Family Member will be responsible for covering the costs of such medical services, treatments, and/or medications.4.The general practitioner online consultation is only applicable to the Insured and/or Designated Family Member whose attained age is 7 or above on the day of the online consultation. The Insured or Designated Family Member may choose to receive online consultation conducted by registered medical practitioners of the designated clinics under the Medical Network in Mainland China of GBAH and prescribed basic medication for a duration of up to 3 days, including basic medication delivery services, provided that the address of the Insured or Designated Family Member is in the same geographical area as the clinic of the registered general practitioner who provides such online consultation. If the Insured and/or Designated Family Member is located in a different geographical area from the clinic of the registered medical practitioner during the online consultation, the service of the Plan shall not cover such online consultation nor any outpatient services. The Company shall not be liable for any losses incurred by the Insured or Designated Family Member.5.The Insured and/or Designated Family Member can receive face-to-face outpatient consultations conducted by registered medical practitioners of the designated clinics under the Medical Network within Designated GBA Cities, Hong Kong or Macau (subject to the area of coverage according to different plan levels as specified in the At-a-Glance Table in the product brochure), and prescribed basic medication for a duration of up to 3 days.6.If the Insured and/or Designated Family Member suffers from a Disability, and following an initial referral confirmed by a GOLDTM doctor of GBAH as Medically Necessary for traditional Chinese medical treatment, the Insured or Designated Family Member shall receive traditional Chinese medical treatment services at designated Chinese medical clinics under the Medical Network within the Designated GBA Cities of GBAH for such Disability. Service shall include consultations, diagnosis, prescribed traditional Chinese medicines for a duration of up to 3 days, and related traditional Chinese medical services and treatments, up to 100 Chinese yuan per outpatient consultation.7.The Insured or Designated Family Member shall receive dental scaling and dental care service at designated dental service centres under GBAH once per Policy Year.8.Upon completion of enrolment for this service under the Plan by the Insured and/or the Designated Family Member, GBAH will proactively reach out the Insured and/or the Designated Family Member. With their consent, an initial assessment of proactive health management to be conducted via face-to-face or online will be arranged by the GOLDTM doctors from GBAH for the Insured and/or Designated Family Member. The first assessment of proactive health management and any subsequent follow-up assessments shall each be considered as 1 outpatient consultation, subject to the maximum number of outpatient consultations per Policy Year.9.GBAH shall offer patients with education of chronic disease prevention. This programme is provided by GOLDTM doctors and nurses of GBAH for the Insured and/or Designated Family Member and which is limited to the Medical Network in Mainland China. Visits to clinics or service centres under Medical Network of GBAH by the Insured and/or Designated Family Member for this Chronic disease management programme shall not be considered as outpatient consultation and shall not be subject to the maximum numbers of outpatient consultation per Policy Year.10.For general practitioner online consultations that exceed the annual policy limit for outpatient services, the Insured and/or Designated Family Member will be responsible for covering the costs of medications and delivery fees.Important Notice:- The information contained in this press release is intended as a general summary of information for reference only. For more details, please refer to relevant product brochures, promotion leaflets, and policy documents. For details regarding the CTF Life “GBA MediAccess” Outpatient Insurance Plan, the terms and conditions of the Plan shall prevail.- This press release does not contain the full provisions of “GBA MediAccess” Outpatient Insurance Plan, and the full terms can be found in the Policy documents. “GBA MediAccess” Outpatient Insurance Plan may serve as standalone plan(s) without bundling with other type(s) of insurance product. Please refer to the main product brochure and policy terms and conditions, as well as the explanatory documents provided by your licensed insurance intermediary, to fully understand the details and complete terms and conditions regarding the mentioned definitions, fees, product features, exclusions, and compensation payment conditions related to “GBA MediAccess” Outpatient Insurance Plan.- Please refer to the product brochure for more information on “GBA MediAccess” Outpatient Insurance Plan: https://www.ctflife.com.hk/pdf/en/products/life-insurance/health/gba-mediaccess-product-brochure.pdf- For further details, please contact CTF Life’s Customer Service Hotline on +852 2866 8898.- This press release is intended to be distributed in Hong Kong only and shall not be construed as an offer to sell or a solicitation to buy or provision of any of our products outside Hong Kong. Chow Tai Fook Life Insurance Company Limited hereby declares that it has no intention to offer to sell, to solicit to buy or to provide any of its products in any jurisdiction other than Hong Kong in which such offer to sell or solicitation to buy or provision of any product of Chow Tai Fook Life Insurance Company Limited is illegal under the laws of that jurisdiction. About CTF LifeChow Tai Fook Life Insurance Company Limited (“CTF Life”) is proud of its rich, 40-year legacy in Hong Kong. CTF Life is a wholly-owned subsidiary of CTF Services Limited (Hong Kong Stock Code: 659) and one of the most well-established life insurance companies in Hong Kong. As a member of Chow Tai Fook Enterprises Limited, CTF Life consistently strengthens its collaboration with the diverse conglomerate of the Cheng family (“Chow Tai Fook Group” or “the Group”) to support customers and their loved ones in navigating life’s journey with personalised planning solutions, lifelong protection and diverse lifestyle experiences. By leveraging the Group’s robust financial strength and strategic investments across the globe, CTF Life aspires to become a leading insurance company in Asia while continuously creating value beyond insurance.About the GBA Healthcare Group (GBAH)The GBA Healthcare Group (GBAH) was established in 2014, a mission driven healthcare company founded in Hong Kong that has been pioneering private public partnerships for healthcare services with various regional governments in the Greater Bay Area (GBA). GBAH is a strategic, controlling healthcare investment of Chow Tai Fook Enterprises Limited, the flagship private investment holding company of the Cheng Family in Hong Kong. Since its establishment, GBAH has delivered primary care training and accreditation to over 3,500 GOLDTM-certified family doctors and nurses in the GBA, jointly built over 220 GOLDTM private-public-partnership clinics in partnership with regional governments, and operated GOLDTM Hong Kong-Macau Residents Healthcare Services Centers within large-scale top-tier public hospitals, offering full-spectrum outpatient and inpatient care. Through such a vast service network, GBAH is creating innovative alternative payment models with commercial health insurers, based on family medicine and preventive care practices, to implement value-based health insurance propositions. The goal of GBAH is to give everyone access to trusted and affordable healthcare, so that everyone can freely pursue their dreams without worrying about their health.Media EnquiriesCTF LifeBranding & CommunicationsDeronie Tan+852 2591 8504deronie.tan@ctflife.com.hkChow Tai Fook Life Insurance Company Limited (Incorporated in Bermuda with limited liability) Copyright 2025 ACN Newswire via SeaPRwire.com.
More
The 15th PropertyGuru Asia Property Awards (Singapore) present new categories amid resilient consumer sentiment ACN Newswire

The 15th PropertyGuru Asia Property Awards (Singapore) present new categories amid resilient consumer sentiment

SOUTHEAST ASIA’S LEADING PROPTECH COMPANY REINVIGORATES SEARCH FOR THE COUNTRY’S FINEST REAL ESTATESINGAPORE, Mar 24, 2025 - (ACN Newswire via SeaPRwire.com) - The 15th edition of the PropertyGuru Asia Property Awards (Singapore) is now open for entries. To commemorate the milestone, the awards programme has been revitalised with the addition of new competitive categories as well as a new venue for 2025.The 15th edition of the PropertyGuru Asia Property Awards (Singapore) is now open for entries, with submissions accepted until 5 September.The latest search for Singapore’s finest real estate unfolds against a backdrop of market resilience and stability. Strong property demand persists despite ongoing challenges faced by property seekers, according to the PropertyGuru Singapore Consumer Sentiment Study H2 2024.The black-tie gala dinner and awards ceremony will be held for the first time at Andaz Singapore. Key dates for the 2025 edition are:5 September 2025 – Entries Close22-26 September 2025 – Site Inspections29 September 2025 – Final Judging31 October 2025 – Gala Dinner and Awards Ceremony in Singapore12 December 2025 – Regional Grand Final Gala Dinner and Awards Presentation in Bangkok, Thailand The 15th PropertyGuru Asia Property Awards (Singapore) programme is part of the broader PropertyGuru Asia Property Awards series, organised by PropertyGuru Group, Southeast Asia’s leading property technology company.Stable sentimentSingapore’s real estate market continues to exhibit resilience, with one in two consumers intending to buy a property within the next five years, according to the PropertyGuru Singapore Consumer Sentiment Study H2 2024.The Sentiment Index—which measures current real estate satisfaction and overall climate, housing affordability, interest rates, perceived government efforts, and property prices—remained stable at 43 points. This represents a slight decrease from the H1 2024 report, which recorded 44 points.This year’s awards mark the debut of several new categories, including Best Renovated Commercial Development; Best Renovated Residential Development; and Best Sustainable Development.Jules Kay, general manager of PropertyGuru Asia Property Awards and EventsJules Kay, general manager of PropertyGuru Asia Property Awards and Events, said: “We are proud to launch the 15th edition of our Awards series in Singapore, presenting well established and new accolades that underline its reputation as one of the greenest and most forward-thinking real estate markets in Asia Pacific. Our 2025 awards aim to recognise an even richer range of options for nature-inspired living and urban comforts in Singapore, illustrating a vision of what tomorrow’s cities can achieve. We are optimistic that demand for quality will stay resilient despite market challenges as we honour more projects that benefit Singapore's diverse communities and safeguard its environment.”Kristin Thorsteins, co-founder and managing partner, Portman Investment Pte Ltd, and chairperson of the PropertyGuru Asia Property Awards (Singapore), with 2024 Best Developer, UOL Group LimitedKristin Thorsteins, co-founder and managing partner, Portman Investment Pte Ltd, and chairperson of the PropertyGuru Asia Property Awards (Singapore), said: "At the 2025 PropertyGuru Asia Property Awards (Singapore), developers have the opportunity to present their achievements on a distinguished platform, showcasing them to the industry at large. Continuously adapting with the times, the awards honour companies and projects that excel not only in raising design and development standards but also in advancing sustainability, lifting communities, and improving the urban fabric of Singapore."Thorsteins leads an independent panel of judges, comprising experts across various segments of the Singapore real estate industry. As the official supervisor, HLB Singapore Foo Kon Tan, part of “2024 Network of the Year” winner HLB International, will maintain the fairness, transparency, and credibility of the selection process.Winners of the 2025 PropertyGuru Asia Property Awards (Singapore) may be eligible to compete for the Best in Asia titles at the 20th PropertyGuru Asia Property Awards Grand Final in December. Historic editionEstablished in 2005, the PropertyGuru Asia Property Awards series celebrates its historic 20th edition this year. The series has expanded over the decades to include markets such as the Middle East, Mainland China, Hong Kong, Macau, Japan, Australia, India, Sri Lanka, Cambodia, Indonesia, Malaysia, the Philippines, Thailand, Vietnam, and Singapore.Winners of the 2025 PropertyGuru Asia Property Awards (Singapore) may be eligible to compete for the Best in Asia titles at the 20th PropertyGuru Asia Property Awards Grand Final in December.At the 2024 Grand Final, eight Best in Asia titles were presented to outstanding companies from Singapore: UOL Group Limited and Singapore Land Group Limited, Pan Pacific Hotels Group, GuocoLand and Hong Leong Holdings Limited, TID Pte. Ltd., and FRX Capital Private Limited.Organised by PropertyGuru Group, the 15th Annual PropertyGuru Asia Property Awards (Singapore) are supported by official portal partner PropertyGuru.com.sg; official magazine Property Report by PropertyGuru; media partners D+A Magazine, SquareRooms, and Tatler Asia Homes; and official supervisor HLB. For more information, email awards@propertyguru.com or visit the official website: AsiaPropertyAwards.com.ABOUT PROPERTYGURU ASIA PROPERTY AWARDSPropertyGuru’s Asia Property Awards, established in 2005, are the region’s most exclusive and prestigious real estate awards programme. The Asia Property Awards are recognised as the ultimate hallmark of excellence in the Asian property sector. Boasting an independent panel of industry experts and trusted supervisors, the Awards have an unparalleled reputation for being credible, ethical, fair, and transparent. In 2025, the Awards series is open to key property markets around the region. The exciting gala events welcome senior industry leaders and top media, as well as reach property agents and consumers via live streaming. Recognising excellence within each Asian market with a variety of categories, including green and sustainable development, each local awards programme will culminate in the PropertyGuru Asia Property Awards Grand Final, which takes place after the PropertyGuru Asia Real Estate Summit during PropertyGuru Week in December 2025. For more information, please visit AsiaPropertyAwards.com.ABOUT PROPERTYGURU GROUPPropertyGuru is Southeast Asia’s leading1 PropTech company, and the preferred destination for over 31 million property seekers2 to connect with over 50,000 agents monthly3 to find their dream home. PropertyGuru empowers property seekers with more than 2.1 million real estate listings4, in-depth insights, and solutions that enable them to make confident property decisions across Singapore, Malaysia, Thailand, and Vietnam.PropertyGuru.com.sg was launched in Singapore in 2007 and since then, PropertyGuru Group has made the property journey a transparent one for property seekers in Southeast Asia. In the last 17 years, PropertyGuru has grown into a high-growth PropTech company with a robust portfolio including leading property marketplaces and award-winning mobile apps across its core markets. For more information, please visit: PropertyGuruGroup.com; PropertyGuru Group on LinkedIn.(1) Based on SimilarWeb data between January 2024 and June 2024.(2) Based on Google Analytics data between January 2024 and June 2024.(3) Based on data between April 2024 and June 2024.(4) Based on data between January 2024 and June 2024.PROPERTYGURU CONTACTS:General Enquiries:Richard Allan Aquino, Head of Brand & Marketing ServicesM: +66 92 954 4154E: allan@propertyguru.com Media & Partnerships:Nate Dacua, Senior Manager, Media and Marketing ServicesM: +66 92 701 2510E: nate@propertyguru.comSales & Nominations:Alicia Loh, Awards Manager (Singapore)M: +65 8382 0078E: alicia@propertyguru.com.sg Copyright 2025 ACN Newswire via SeaPRwire.com.
More
Summit Group Holds Iftar in Singapore for About 200 Migrant Workers, Including Bangladeshis ACN Newswire

Summit Group Holds Iftar in Singapore for About 200 Migrant Workers, Including Bangladeshis

SINGAPORE, Mar 21, 2025 - (ACN Newswire via SeaPRwire.com) - To show appreciation for migrant workers in Singapore, many of whom are Bangladeshi, Summit Power International Limited (“SPIL”) has hosted a breaking of fast (Iftar) for about 200 workers during the holy month of Ramadan.Mr Muhammed Aziz Khan, PBM (centre), Founder Chairman of Summit Group, broke fast with migrant workers in Singapore, many of whom are Bangladeshi nationalsMr Muhammed Aziz Khan, PBM, the Founder Chairman of the Summit Group, broke fast with the workers at a workers’ dormitory in Space@Tuas, on 20 March 2024. Another 200 meals were provided for Muslim workers who were not able to attend the event physically.SPIL also presented gifts to 1400 workers. Appreciation cards and crafts – prepared by about 50 students – were also presented to the workers at the dormitory. The students are from the Big Heart Student Care Services at Zhangde Primary School and the German European School Singapore (“GESS”) in Singapore. The cards and crafts were presented by teachers from GESS on behalf of the students.This is the first Singapore Iftar event sponsored by SPIL, the Singapore-headquartered parent of Bangladesh’s largest private sector power generation company.Besides Iftar, SPIL is also engaged in other corporate social responsibility (“CSR”) efforts in Bangladesh, including charity donations for neuro-divergent children, participating in UNICEF initiatives to help school dropouts, as well as supporting scientific research for nutrition and online education, among others.Mr Muhammed Aziz Khan, PBM said, “Throughout the years, social responsibility remains a core principle of the Summit Group. Bangladeshi nationals comprise a significant number of the migrant workers in Singapore. This year’s Iftar that we sponsored in Singapore underscores our efforts to give back.”“I am touched that young students from the two schools have expressed their appreciation to the migrant worker community in Singapore,” he added.Mr Muhammed Aziz Khan, PBM, a Singaporean of Bangladeshi origin, was awarded the Public Service Medal (COVID-19) in October 2023 for engaging and helping Bangladeshi workers who were isolated in local dormitories during the pandemic.Ms Patricia Amorim and Ms Marieke Bink, teachers at GESS, said, “We were thrilled to have collaborated with students of Big Heart for a meaningful card-making activity, bringing together our Grade 6-8 students with younger brothers and sisters from Big Heart to create heartfelt messages for migrant workers. This event not only fostered creativity but also facilitated genuine interactions between the students as they shared stories and ideas. The cards produced are a beautiful testament to their teamwork and compassion, showcasing the power of community and the importance of supporting those who contribute so much to our society.”Shaina, a representative of Big Heart Student Care, said, “We are delighted to partner with the German European School Singapore for a meaningful initiative aimed at giving back to the community. Last Friday, students gathered to create heartfelt cards for migrant workers, expressing gratitude and appreciation for their vital contributions to Singapore’s growth and development. This significant event not only instilled a deep sense of gratitude in the students but also helped foster new friendships and lasting memories. It was a powerful reflection of the true spirit of multiculturalism and inclusivity—values that have brought us together and been instrumental in Singapore’s success over the past 60 years."About Summit Power International Limited (“SPIL”)SPIL is the largest Independent Power Producer (IPP) in Bangladesh, reflecting 17% of the country's total private installed capacity and 10% of total installed capacity. Summit owns and operates a total of 18 power plants. It also operates Bangladesh’s second Floating Storage and Regasification Unit (FSRU) and LNG import terminal with daily regasification capacity of 500 million cubic feet.SPIL’s partners include JERA, Mitsubishi Corporation and Taiyo Insurance Company of Japan and GE of the USA. In July, 2023, Denmark's Copenhagen Infrastructure Partners (CIP), Copenhagen Offshore Partners (COP) in association with Summit Group, submitted a foreign direct investment proposal valued at USD 1.3 billion to develop the country’s first 500 MW utility-scale offshore wind energy project.SPIL is the leading infrastructure conglomerate in Bangladesh with diversified interests in power generation, energy, telecommunications, ports and real estate.Learn more at: www.summitpowerinternational.com Media ContactWeR1 Consultants Pte LtdIsaac TangWhatsApp (Text): (65) 9748 0688summit@wer1.net Copyright 2025 ACN Newswire via SeaPRwire.com.
More
Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency JCN Newswire

Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

HONG KONG, Mar 24, 2025 - (ACN Newswire via SeaPRwire.com) - Galaxy Payroll Group Limited (NASDAQ: GLXG) (the “Company”) announced that, on March 17, 2025, the Company received a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that based on the closing bid price of the Company for the period from January 31, 2025 to March 14, 2025, the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share.The notification has no immediate effect on the listing of the Company’s ordinary shares. Nasdaq has provided the Company with a 180 calendar days compliance period, or until September 15, 2025, in which to regain compliance with Nasdaq continued listing requirement. In the event that the Company does not regain compliance in the compliance period, the Company may be eligible for an additional 180 calendar days, should the Company meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and is able to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. However, if it appears that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that the Company’s securities will be subject to delisting.The Company is currently evaluating options to regain compliance and intends to timely regain compliance with Nasdaq’s continued listing requirement. Although the Company will use all reasonable efforts to achieve compliance with Rule 5550(a)(2), there can be no assurance that the Company will be able to regain compliance with that rule or will otherwise be in compliance with other Nasdaq continued listing requirement.Forward-Looking StatementsCertain statements in this press release are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions in this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s filings with the SEC.About Galaxy Payroll Group LimitedGalaxy Payroll Group Limited is a leading payroll outsourcing service provider based in Hong Kong. The company specializes in delivering HR and payroll solutions to multinational companies across various industries. With a focus on innovation and client satisfaction, GLXG operates in Hong Kong, Taiwan, Macau, and the PRC, offering payroll outsourcing, employment services, and consultancy to businesses of all sizes.For enquiry, please contact Intelligent Joy Limited:Rosanne RenPhone: (852) 3594 6407Email: pr-team@intelligentjoy.com Copyright 2025 JCN Newswire via SeaPRwire.com.
More
DENSO the First Company Headquartered in Japan to Acquire EcoPass Certification from Catena-X JCN Newswire

DENSO the First Company Headquartered in Japan to Acquire EcoPass Certification from Catena-X

TOKYO, Mar 24, 2025 - (JCN Newswire via SeaPRwire.com) - DENSO CORPORATION today announced it has acquired the EcoPass(1) certification from Catena-X(2), a dataspace(3) for securely exchanging data across automotive supply chains in Europe. DENSO achieved the certification on February 14, 2025, making it the first Business Application Provider(4) of Catena-X globally headquartered in Japan to do so.This certification demonstrates that the DENSO application under development for Digital Product Passport(5) (DPP), conforms to Catena-X rules and ensures secure data exchange between approved stakeholders.In recent years, there has been rising demand for society as a whole to become carbon neutral and to shift to a more circular economy, in which resources are circulated in the economic system. To manufacture products in a more eco-friendly manner, DPP initiatives are under way around the world to digitalize information about manufacturers, materials used, CO2 emissions, and the recyclability of products. There is a demand to build a mechanism for data linkage initiative across companies, industries, and national borders.In Japan, a project to build the Ouranos Ecosystem, led by Japan’s Ministry of Economy, Trade and Industry, started in April 2023. DENSO has identified issues and studied business requirements for data collaboration in the automotive industry.(6)In Europe, Catena-X is being operated as an initiative for data collaboration in the automotive industry, and DENSO has joined Catena-X in 2021 as an automotive parts manufacturer with global operations. And now DENSO has acquired EcoPass certification from Catena-X as first company headquartered in Japan.Since then, based on the European Battery Regulation(7), introduction of the Battery Passport for battery products, such as automotive and industrial batteries, is expected to be legally required from February 2027 as the first use case of DPPs.DENSO has been developing(8) a Battery Passport application for the future. The completed application will be deployed in-house and made available to users in the supply chains as a secure data exchange service verified by the EcoPass certification to assist the auto industry in ensuring compliance with laws and regulations.This application uses a Software-as-a-Service product, including EDC(9) connector for dataspace connectivity, developed by T-Systems, an IT services subsidiary of Deutsche Telekom—one of Europe’s largest telecommunications companies and a global leader. T-Systems is one of the key developers of the Catena-X software stack and holds multiple Catena-X certifications, including as a Business Application Provider.DENSO remains committed to contributing to the realization of a sustainable society by promoting a circular value chain around the world.(1) EcoPass: A function to realize data exchange among companies in conformity with the Catena-X rules based on data models defined by Catena-X(2) Catena-X: A platform operated by German automakers and suppliers to securely share data, such as parts information, among concerned companies(3) Dataspace: A standardized mechanism for data sharing and linkage across companies and organizations while ensuring mutual reliability(4) Business Application Provider: A company which provides solutions that meet specific business needs based on use cases defined by Catena-X(5) Digital Product Passport: A digital certificate which records various kinds of information, including manufacturers, materials used, recyclability, and dismantling methods, that proves the sustainability of products to ensure traceability throughout the product life cycle(6) NTT DATA and DENSO Start to Build an Industry-wide Ecosystem for EV Batteries | Newsroom | News | DENSO – DENSO Corporation / Crafting the Core /(7) European Battery Regulation: Regulation effective in Europe in August 2023 to promote the production and use of sustainable battery products(8) Developing the Battery Passport: A Foundation for Japanese Industry | DRIVEN BASE – DENSO(9) EDC: Short for Eclipse Dataspace Components. A standard component for secure communication among companies while ensuring data sovereignty in Catena-X Copyright 2025 JCN Newswire via SeaPRwire.com.
More
DEXIS 将于 2025 年 IDS 展会中展示尖端创新技术 ACN Newswire

DEXIS 将于 2025 年 IDS 展会中展示尖端创新技术

贵格镇,2025年3月24日 - (亚太商讯 via SeaPRwire.com) - 全球牙科影像技术领导品牌 DEXIS 欣然宣布,将参加于德国科隆举办的 2025 年国际牙科展(International Dental Show, IDS)。DEXIS 将展示其最新技术,这些技术整合于 DEXIS 数字生态系统中。该平台由 AI 技术驱动,能连接从诊断到治疗交付的每个数字流程步骤。这一整合式解决方案结合了人工智能、2D 与 3D 影像、口内扫描、诊断分析与治疗规划,帮助牙科诊所简化流程并提升生产力。“我们非常期待能在 IDS 展会上,让与会者抢先一睹我们的最新技术,”DEXIS 总裁 Robert Befidi 表示。“我们的所有创新,皆旨在改善患者互动体验,并协助牙科诊所提升效率与效能。我们也十分期待将这些产品带给牙科专业人员,展示其强大的应用能力。”这些创新技术中,包含 DEXIS 口内扫描产品线的令人振奋的新进展。参观者将可抢先目睹 DEXIS 正在开发中的全新口内扫描仪 —— Imprevo。该设备拥有全新时尚外形、重新设计的硬件架构,以及 AI 驱动的算法,将成为 DEXIS IOS 产品线中的高效旗舰新星。此外,DEXIS 也将预览其口内扫描软件 IS ScanFlow 的最新版本 —— IS ScanFlow 2.0。新版本加入了全新功能“微笑可视化工具(Smile Visualizer)”,协助牙科专业人员向患者展示疗程前后的拟真微笑模拟画面,帮助患者更清楚理解并接受治疗建议。DEXIS 也将发布 ORTHOPANTOMOGRAPH™ OP 3D™ EX 的更新版本,未来将新增头颅定位影像(Cephalometric Imaging)功能。这项全新头颅模式采用了 DEXIS 专利的 ORTHOceph™ Plus 设计,将支持包括侧颅与儿童侧颅影像、前后位影像以及腕骨摄影*等临床所需的协议,并具备快速扫描时间与低剂量的优势。此外,DEXIS 的 3D 影像产品线也将在 ORTHOPANTOMOGRAPH™ OP 3D™ LX 中新增自动剂量控制(Automatic Dose Control)功能。该功能能根据患者解剖结构自动设定曝光参数,以达成最佳影像质量与辐射剂量控制。早期使用者对此功能反应热烈,其中来自圣地亚哥健康中心的 Katya Archambault 医师表示:“新的自动剂量控制功能,是我人生中少数不需要怀疑的事情之一。它不仅提升了影像质量,也让质量更稳定。我对结果无可挑剔。”DEXIS 将同步展示其数字生态系统核心软件 DTX Studio™ Clinic 的多项全新功能。DTX Studio Clinic 以全面整合各种患者数据格式而闻名,能有效简化诊断流程、患者沟通、治疗计划与手术导板的制作。此次新增功能重点之一,是一套专为种植牙治疗规划流程优化所设计的工具组。用户现在可在椅旁快速完成种植牙规划,并在 3 分钟内自动生成手术导板。此外,软件也导入了“辅助式种植牙规划模块”,可自动建立初步植体定位,搭配“面部扫描整合工具”,可将面部扫描与 3D X 光影像结合,进一步提升治疗计划的准确度与效率。参观者也将抢先一睹即将在 DTX Studio Clinic 未来版本中推出的创新功能。其中包括一项 AI 驱动的根管治疗功能,能以 3D 视觉化方式呈现根管结构,有助于提升诊断准确性与治疗效率。此外,升级版的焦点区域检测工具将同步展出,除了增强口内 X 光中牙齿区域的可视化效果,还能自动识别额外八项牙科病征。DTX Studio Clinic 也将推出全新的云端解决方案,协助临床医生将诊所联网并整合所有数据于同一平台。此功能设计旨在提升团队协作效率、简化诊所工作流程,进而优化运营与患者护理成果。这些技术进展展现了牙科科技的未来趋势,使 DTX Studio Clinic 成为现代牙科不可或缺的核心组件。DEXIS 诚挚邀请所有 IDS 与会者莅临 11.2 馆 K050 / L069 展位,亲自体验 DEXIS 精心打造的各项创新。现场将有专业团队进行实时操作展示并回答相关问题。目前,DEXIS 在全球已有超过 165,000 套解决方案投入临床使用,持续引领牙科影像质量与可靠性的业界标准。如欲了解 DEXIS 于 IDS 展会的更多信息,请访问 DEXIS @ IDS 2025。关于 DEXISDEXIS 在数字放射影像领域拥有超过 70 年的全球领先品牌地位。如今,DEXIS 汇聚了最受信赖的 3D 影像、口内扫描解决方案与诊断软件品牌,为您提供完整的数字诊断解决方案。我们屡获殊荣的创新技术能提升诊断准确性、加速工作流程,并提供更简单的治疗途径,从而改善患者的治疗效果。欲了解更多信息,请访问 www.dexis.com。关于 Envista Holdings CorporationEnvista 是由 30 多个备受信赖的牙科品牌组成的全球企业集团,其中包括 Nobel Biocare、Ormco、DEXIS 和 Kerr,共同秉持着“携手专业人士,改善人们生活”的使命。Envista 通过业界领先的牙科消耗品、解决方案、技术和服务,帮助客户提供最佳的患者护理。Envista 的综合产品组合涵盖牙科植体与治疗方案、正畸技术及数字影像技术,满足牙科医生在诊断、治疗与预防牙科疾病以及提升美学效果的广泛临床需求。Envista 凭借其 Envista Business System(EBS)方法论、经验丰富的领导团队,以及以持续改进、创新承诺和深厚客户导向为核心的企业文化,能够全面满足全球牙科专业人士的需求。Envista 是全球最大的牙科产品公司之一,在牙科行业中最具吸引力的细分市场拥有强劲的市场地位。欲了解更多信息,请访问 www.envistaco.com。DXIS01006/Rev00*Carpus 是一个可选的成像程序联系方式Maria PenalozaMedia & Content Strategy Managermaria.penaloza@issuerdirect.comMichelle CabralSenior Marketing Director, DEXIS michelle.cabral@envistaco.com来源: Envista Copyright 2025 亚太商讯 via SeaPRwire.com.
More